Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
OKUWA, 46% Increase in Ordinary Profit for The Current Fiscal Year
8217 OKUWA CO., LTD. 【J-GAAP】
Earnings ReportOKUWA CO., LTD. <8217> [TSE Prime] announced its financial results in the afternoon session on April 1st (13:00). The consolidated ordinary profit for the fiscal year ending February 2025 dropped 53.5% from the previous period to 1.44 billion yen. In the fiscal year ending February 2026, the profit is expected to recover to 45.6% to 2.1 billion yen. This will be the third consecutive term of revenue growth.
In the most recent three-month period, from December to February (4Q), the consolidated ordinary profit decreased to 1.24 billion yen, a 29.8% decrease compared to the same period last year. The operating profit margin worsened from 2.6% in the same period last year to 1.8%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 246,877 | 2,927 | 3,148 | 928 | 21.2 | 26 | Apr 3, 2023 | J-GAAP |
Feb, 2024 | 247,378 | 2,888 | 3,098 | 1,000 | 22.8 | 26 | Apr 2, 2024 | J-GAAP |
Feb, 2025 | 250,150 | 1,328 | 1,442 | -2,381 | -55.9 | 26 | Apr 1, 2025 | J-GAAP |
YoY | +1.1% | -54.0% | -53.5% | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2025 Guidance | 250,150 | 1,320 | 1,440 | -2,380 | -55.9 | 26 | Mar 25, 2025 | J-GAAP |
Feb, 2025 Results | 250,150 | 1,328 | 1,442 | -2,381 | -55.9 | 26 | Apr 1, 2025 | J-GAAP |
Revision Rate | 0.0% | +0.6% | +0.1% | 0.0% | -0.1% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 | 122,558 | 246 | 313 | 87 | 2.0 | 13 | Oct 1, 2024 | J-GAAP |
Mar - Aug, 2025 Guidance | 126,500 | 300 | 350 | 100 | 2.4 | 13 | Apr 1, 2025 | J-GAAP |
YoY | +3.2% | +22.0% | +11.8% | +14.9% | +19.4% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2024 | 247,378 | 2,888 | 3,098 | 1,000 | 22.8 | 26 | Apr 2, 2024 | J-GAAP |
Feb, 2025 | 250,150 | 1,328 | 1,442 | -2,381 | -55.9 | 26 | Apr 1, 2025 | J-GAAP |
Feb, 2026 Guidance | 259,000 | 2,100 | 2,100 | 800 | 19.2 | 26 | Apr 1, 2025 | J-GAAP |
YoY | +3.5% | +58.1% | +45.6% | - | - |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec - Feb, 2023 | 64,742 | 1,695 | 1,771 | 338 | 7.7 | 2.6 | Apr 2, 2024 | J-GAAP |
Mar - May, 2024 | 58,697 | -38 | 6 | -56 | -1.3 | -0.1 | Jun 27, 2024 | J-GAAP |
Jun - Aug, 2024 | 63,861 | 284 | 307 | 143 | 3.3 | 0.4 | Oct 1, 2024 | J-GAAP |
Sep - Nov, 2024 | 61,169 | -119 | -115 | -201 | -4.7 | -0.2 | Dec 27, 2024 | J-GAAP |
Dec - Feb, 2024 | 66,423 | 1,201 | 1,244 | -2,267 | -53.2 | 1.8 | Apr 1, 2025 | J-GAAP |
YoY | +2.6% | -29.1% | -29.8% | - | - |
Related Articles
Nikkei 225 close on the 1st = rebound for the first time in 4 days, 6 yen higher to 35,624 yen
Eltes, Last Fiscal Year Ordinary Profit Revised Downward to an Unexpected 48% Decrease
INTRANCE, Last Fiscal Year Net Income Revised Downward to a Loss
MrMax Holdings, Last Fiscal Year Ordinary Profit Revised Upward by 16%, Dividend Revised Upward by 3 yen
NIPPON FILCON, Dec-Feb (1Q) Net Income Turns to Loss
Nikkei 225 open on the 1st = 343 yen higher, 35,961 yen
Kidswell Bio, The Current Fiscal Year Ordinary Profit Loss to Narrow
H.I.S., Nov-Jan (1Q) Ordinary Profit Increases by 67%
Japan Process Development, The Current Fiscal Year Net Income Revised Upward by 85%, Raises Record High Profit Forecast, Dividend Revised Upward by 2 yen
Open House, First Half Ordinary Profit Revised Upward to an Unexpected 22% Increase, Highest in Two Terms, Full Year also Increased, Dividend Revised Upward by 10 yen